BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 37721288)

  • 1. Olfactory dysfunction and its related molecular mechanisms in Parkinson's disease.
    Gu Y; Zhang J; Zhao X; Nie W; Xu X; Liu M; Zhang X
    Neural Regen Res; 2024 Mar; 19(3):583-590. PubMed ID: 37721288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.
    Chase BA; Markopoulou K
    Front Neurol; 2020; 11():447. PubMed ID: 32547477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory Dysfunction in Neurodegenerative Diseases.
    Marin C; Vilas D; Langdon C; Alobid I; López-Chacón M; Haehner A; Hummel T; Mullol J
    Curr Allergy Asthma Rep; 2018 Jun; 18(8):42. PubMed ID: 29904888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
    Bang Y; Lim J; Choi HJ
    Arch Pharm Res; 2021 Jun; 44(6):588-604. PubMed ID: 34145553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Olfactory Function by Iranian Smell Diagnostic Test in Patients with Parkinson's disease in North of Iran.
    Kiakojuri K; Pouladi L; Saadat P; Ahmadi Ahangar A; Gholinia H
    Iran J Otorhinolaryngol; 2021 Sep; 33(118):271-279. PubMed ID: 34692574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of Non-Motor Symptoms in Parkinson's Disease.
    Kumaresan M; Khan S
    Cureus; 2021 Feb; 13(2):e13275. PubMed ID: 33728210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.
    Rolheiser TM; Fulton HG; Good KP; Fisk JD; McKelvey JR; Scherfler C; Khan NM; Leslie RA; Robertson HA
    J Neurol; 2011 Jul; 258(7):1254-60. PubMed ID: 21287185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of olfactory dysfunction in a mouse model of Parkinson's disease via enhancing GABAergic signaling.
    Liu XY; Wang K; Deng XH; Wei YH; Guo R; Liu SF; Zhu YF; Zhong JJ; Zheng JY; Wang MD; Ye QH; He JQ; Guo KH; Zhu JR; Huang SQ; Chen ZX; Lv CS; Wen L
    Cell Biosci; 2023 Jun; 13(1):101. PubMed ID: 37270503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson's disease.
    Nabizadeh F; Pirahesh K; Khalili E
    Neurol Sci; 2022 Jul; 43(7):4193-4201. PubMed ID: 35166976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis].
    Herting B; Bietenbeck S; Scholz K; Hähner A; Hummel T; Reichmann H
    Nervenarzt; 2008 Feb; 79(2):175-84. PubMed ID: 17701389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Mitochondrial Dysfunction on Dopaminergic Neurons in the Olfactory Bulb and Odor Detection.
    Paß T; Aßfalg M; Tolve M; Blaess S; Rothermel M; Wiesner RJ; Ricke KM
    Mol Neurobiol; 2020 Sep; 57(9):3646-3657. PubMed ID: 32564285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.
    Fullard ME; Morley JF; Duda JE
    Neurosci Bull; 2017 Oct; 33(5):515-525. PubMed ID: 28831680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study.
    Stewart CB; Ledingham D; Foster VK; Anderson KN; Sathyanarayana S; Galley D; Pavese N; Pasquini J
    Front Neurol; 2023; 14():1155669. PubMed ID: 37122303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory impairment in Parkinson's disease is a consequence of central nervous system decline.
    Iannilli E; Stephan L; Hummel T; Reichmann H; Haehner A
    J Neurol; 2017 Jun; 264(6):1236-1246. PubMed ID: 28550478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.
    Lee HM; Koh SB
    J Mov Disord; 2015 May; 8(2):92-7. PubMed ID: 26090081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced cerebral blood flow in an
    Biju KC; Shen Q; Hernandez ET; Mader MJ; Clark RA
    J Cereb Blood Flow Metab; 2020 Dec; 40(12):2441-2453. PubMed ID: 31856640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of anxiety in early Parkinson's disease: A clinical and biomarker study.
    Wang H; Zhao Y; Schrag A
    Eur J Neurol; 2023 Sep; 30(9):2661-2668. PubMed ID: 37227928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's disease.
    Mertens AT; Santo JB; Markopoulou K; Chase BA
    Clin Park Relat Disord; 2019; 1():13-20. PubMed ID: 34316593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the potential role of serum miR-20a as a biomarker for olfactory dysfunction in patients with Parkinson's disease.
    Liu H; Zhao H; Bao Y; Yang J; Xie H; Huang D
    Eur Arch Otorhinolaryngol; 2023 Oct; 280(10):4509-4517. PubMed ID: 37258792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.